MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2019 International Congress

    Dancing larynx syndrome associated with trigeminal neuralgia secondary to multiple sclerosis

    D. Shpiner, M. Ortega, H. Moore (Miami, FL, USA)

    Objective: To describe a rare a case of a patient who developed “dancing larynx”-like syndrome after gamma knife radiation for trigeminal neuralgia (TN) associated with…
  • 2019 International Congress

    The short-term effect of combined facial exercise with botulinum toxin A injection in clinical practice in Thai patients with hemifacial spasm: A randomized controlled pilot crossover study

    P. Soontrapa, Y. Pitakpatapee, A. Suengtaworn, J. Srikajon, T. Sangpeamsook, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To compare the efficacy of combined facial exercise with BTX-A injection with BTX-A injection alone measured by the total HFS-30 (tHFS-30) score. Background: Hemifacial…
  • 2019 International Congress

    Botulinum Neurotoxin (BoNT) treatment in functional movement disorders: an extended follow up

    J. Dijk, M. Tijssen, J. Koelman, Y. Dreissen, F. Lambert (Groningen, Netherlands)

    Objective: To assess the long term effect of treatment with botulinum neurotoxin (BoNT) in patients with functional jerky or tremorous movement disorders. Background: Treatment options for…
  • 2019 International Congress

    Botulinum toxin treatment of muscle spasms in a case of Satoyoshi syndrome

    I. Bledsoe (San Francisco, CA, USA)

    Objective: To describe improvement in muscle spasms of the jaw and upper limb associated with Satoyoshi syndrome using botulinum toxin injections. Background: Satoyoshi syndrome is…
  • 2019 International Congress

    Hemifacial spasm management: 26-year experience

    Y. Herrero-Infante, A. Rodriguez-Sanz, J. Mañez-Miró, F. Vivancos-Matellano (Madrid, Spain)

    Objective: To analyze the causes of hemifacial spasm as well as the efficacy and safety of long term treatment with botulinum toxin (BT). Background: Hemifacial…
  • 2019 International Congress

    Hemi masticatory spasm (HMS) : Series of 7 cases

    D. Radhakrishnan, V. Goyal, G. Shukla, M. Singh (New Delhi, India)

    Objective: To report retrospective review of seven cases of Hemi masticatory spasm (HMS), supported by electrophysiological and clinical findings. Background: Hemi masticatory spasm (HMS) is a rare…
  • 2019 International Congress

    A case of hemimasticatory spasm with well therapeutic response to serial injections of botulinum toxin

    SK. Yang, JJ. Lin (Changhua County, Taiwan)

    Objective: To report a case with hemimasticatory spasm responsive to serial botulinum toxin injections. Background: Hemimasticatory spasm is a rare neurologic disorder characterized by involuntary…
  • 2019 International Congress

    Development of a patient-reported Botulinum Toxin Response Scale (BTRS) for neurological disorders: a feasibility study.

    D. Gupta, C. Gao, S. Pullman (Burlington, VT, USA)

    Objective: To assess the feasibility of developing a patient-reported Botulinum Toxin Response Scale (BTRS) for different neurological conditions. Background: Botulinum toxin (BoNT) is a highly…
  • 2019 International Congress

    Onset of action for rimabotulinumtoxinB in the treatment of adult sialorrhea

    L. Bahroo, S. Isaacson, R. Pahwa, D. Chary, T. Clinch, M. Lew (Washington, DC, USA)

    Objective: To assess the onset of action for rimabotulinumtoxinBinjections in the salivary glands for the treatment of sialorrhea. Background: Sialorrhea (drooling) causes significant morbidity including impaired oral…
  • 2019 International Congress

    The effects of onabotulinum toxin on neurophysiological tests in patients with hemifacial spasm

    O. Kocak, A. Tokcaer (Ankara, Turkey)

    Objective: We aimed to investigate effects of onabotulinum toxin (OnaBoNT) on clinical and neurophysiological findings of patients with hemifacial spasm (HFS). Background: There is a…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 15
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley